Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage.

F Mateos(Universidad Autónoma de Madrid), Irving H. Fox(Takeda (United States)), Manuel L. Jiménez(Universidad Autónoma de Madrid), Juan Puig(Hospital Universitario La Paz)
Journal of Clinical Investigation
March 1, 1987
10.1172/jci112893
Cited by 78

Related Papers

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
The safety of vedolizumab for ulcerative colitis and Crohn's disease
|Gut|2016|810
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694